Mar 28 |
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
|
Mar 28 |
Earnings Scheduled For March 28, 2024
|
Mar 27 |
Iterum Therapeutics's Earnings: A Preview
|
Mar 21 |
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
|
Mar 15 |
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
|
Mar 7 |
Iterum (ITRM) Plans Early Submission of UTI Drug NDA, Stock Up
|
Mar 6 |
Iterum spikes on accelerated timeline for FDA filing
|
Mar 6 |
Iterum Therapeutics Provides Business Update
|
Feb 1 |
Steven Cohen's Point72 Asset Management Acquires New Stake in Iterum Therapeutics PLC
|
Jan 30 |
Iterum meets main goal in late trial for uUTI treatment with oral sulopenem
|